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Abstract
The widely used electroencephalogram-based indices for depth-of-anesthesia monitoring assume 
that the same index value defines the same level of unconsciousness for all anesthetics. In contrast, 
we show that different anesthetics act at different molecular targets and neural circuits to produce 
distinct brain states that are readily visible in the electroencephalogram. We present a two-part 
review to educate anesthesiologists on use of the unprocessed electroencephalogram and its 
spectrogram to track the brain states of patients receiving anesthesia care. Here in Part I, we 
review the biophysics of the electroencephalogram, and the neurophysiology of the 
electroencephalogram signatures of three intravenous anesthetics: propofol, dexmedetomidine and 
ketamine; and four inhaled anesthetics: sevoflurane, isoflurane, desflurane and nitrous oxide. Later 
in Part II, we discuss patient management using these electroencephalogram signatures. Use of 
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these electroencephalogram signatures suggests a neurophysiologically-based paradigm for brain-
state monitoring of patients receiving anesthesia care.
The Electroencephalogram and Brain Monitoring under General Anesthesia
Almost 80 years ago, Gibbs, Gibbs and Lenox demonstrated that systematic changes occur 
in the electroencephalogram and patient arousal level with increasing doses of ether or 
pentobarbital. They stated that “a practical application of these observations might be the 
use of electroencephalogram as a measure of the depth of anesthesia.”1 Several subsequent 
studies reported on the relationship between electroencephalogram activity and the 
behavioral states of general anesthesia.2–6 Faulconer showed in 1949 that a regular 
progression of the electroencephalogram patterns correlated with the concentration of ether 
in arterial blood.7 Linde and colleagues used the spectrum—the decomposition of the 
electroencephalogram signal into the power in its frequency components—to show that 
under general anesthesia the electroencephalogram was organized into distinct oscillations at 
particular frequencies.8,9 Bickford and colleagues introduced the compressed spectral array 
or spectrogram to display the electroencephalogram activity of anesthetized patients over 
time as a three-dimensional plot (power by frequency versus time).10,11 Fleming and Smith 
devised the density-modulated or density spectral array, the two-dimensional plot of the 
spectrogram for this same purpose.12,13 Levy later suggested using multiple 
electroencephalogram features to track anesthetic effects.14 Despite further documentation 
of systematic relationships among anesthetic doses, electroencephalogram patterns and 
patient arousal levels,4,15–20 use of the unprocessed electroencephalogram and the 
spectrogram to monitor the states of the brain under general anesthesia and sedation never 
became a standard practice in anesthesiology.
Instead, since the 1990s, depth-of-anesthesia has been tracked using indices computed from 
the electroencephalogram and displayed on brain monitoring devices.21–25 The indices have 
been developed by recording simultaneously the electroencephalogram and the behavioral 
responses to various anesthetic agents in patient cohorts.26 Some of the indices have been 
derived by using regression methods to relate selected electroencephalogram features to the 
behavioral responses.26–29 One index has been constructed by using classifier methods to 
derive a continuum of arousal levels from awake to profound unconsciousness from visually 
categorized electroencephalogram recordings.30,31 Another index has been constructed by 
relating the entropy of the electroencephalogram signal—its degree of disorder—to the 
behavioral responses of the patients.32,33 The indices are computed from the 
electroencephalogram in near-real-time and displayed on the depth-of-anesthesia monitor as 
values scaled from 0 to 100, with low values indicating greater depth of anesthesia. The 
algorithms used in many of the current depth-of-anesthesia monitors to compute the indices 
are proprietary.
Although the electroencephalogram-based indices have been in use for nearly 20 years, there 
are several reasons why they are not part of standard anesthesiology practice. First, use of 
electroencephalogram-based indices does not ensure that awareness under general anesthesia 
can be prevented.34,35 Second, these indices, which have been developed from adult patient 
cohorts, are less reliable in pediatric populations.36,37 Third, because the indices do not 
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relate directly to the neurophysiology of how a specific anesthetic exerts its effects in the 
brain, they cannot give an accurate picture of the brain’s responses to the drugs. Finally, the 
indices assume that the same index value reflects the same level of unconsciousness for all 
anesthetics. This assumption is based on the observation that several anesthetics, both 
intravenous and inhaled agents, eventually induce slowing in the electroencephalogram 
oscillations at higher doses.1,4,22 The slower oscillations are assumed to indicate a more 
profound state of general anesthesia. Two anesthetics whose electroencephalogram 
responses frequently lead clinicians to doubt index readings are ketamine38,39 and nitrous 
oxide.40–42 These agents are commonly associated with faster electroencephalogram 
oscillations that tend to increase the value of the indices at clinically accepted doses. Higher 
index values cause concern as to whether the patients are unconscious. At the other extreme, 
dexmedetomidine can produce profound slow electroencephalogram oscillations43 and low 
index values consistent with the patient being profoundly unconscious. However, the patient 
can be easily aroused from what is a state of sedation rather than unconsciousness.43,44
These ambiguities in using electroencephalogram-based indices to define brain states under 
general anesthesia and sedation arise because different anesthetics act at different molecular 
targets and neural circuits to create different states of altered arousal,45,46 and as we show, 
different electroencephalogram signatures.43,47 The signatures are readily visible as 
oscillations in the unprocessed electroencephalogram and its spectrogram. We relate these 
oscillations to the actions of the anesthetics at specific molecular targets in specific neural 
circuits.
Therefore, we propose a new approach to brain monitoring of patients receiving general 
anesthesia or sedation: train anesthesiologists to recognize and interpret anesthetic-induced 
brain states defined by drug-specific neurophysiological signatures observable in the 
unprocessed electroencephalogram and the spectrogram. The new concept of defining the 
anesthetic state by using drug-specific electroencephalogram signatures that relate to 
molecular and neural circuit mechanisms of anesthetic action would allow anesthesiologists 
to make more detailed and accurate assessments than those based on electroencephalogram-
based indices. The potential benefits of using the unprocessed electroencephalogram to 
monitor anesthetic states have been recently stated.48,49 Current brain monitors display the 
unprocessed electroencephalogram and the spectrogram.22,31,50
To define anesthetic states in terms of drug-specific electroencephalogram signatures that 
relate to molecular and neural circuit mechanisms of anesthetic action, we synthesize 
different sources and levels of information: 1) formal behavioral testing along with 
simultaneous electroencephalogram recordings or human intracranial recordings during 
anesthetic administration; 2) clinical observations of behavior along with simultaneous 
electroencephalogram recordings during anesthetic administration; 3) the neurophysiology 
and the molecular pharmacology of how the anesthetics act at specific molecular targets in 
specific circuits; 4) the neurophysiology of altered states of arousal such as non-REM sleep, 
coma (medically induced, pathologic, hypothermia-induced), hallucinations and paradoxical 
excitation; 5) time-frequency analyses of high-density electroencephalogram recordings; and 
6) mathematical modeling of anesthetic actions in neural circuits.
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We present this new education paradigm in two parts. Here, in Part I, we review the basic 
neurophysiology of the electroencephalogram, and the neurophysiology and the 
electroencephalogram signatures of three intravenous anesthetics: propofol, 
dexmedetomidine and ketamine; and four inhaled anesthetics: sevoflurane, isoflurane, 
desflurane and nitrous oxide. We explain, where possible, how the anesthetics act at specific 
receptors in specific neural circuits to produce the observed electroencephalogram 
signatures. In Part II, we discuss how knowledge of the different electroencephalogram 
signatures may be used in patient management.
The Electroencephalogram: A Window into the Brain’s Oscillatory State
Coordinated action potentials, or spikes, transmitted and received by neurons, are one of the 
fundamental mechanisms through which information is exchanged in the brain and central 
nervous system (fig. 1A).51,52 Neuronal spiking activity generates extracellular electrical 
potentials,53 composed primarily of post-synaptic potentials and neuronal membrane 
hyperpolarization (fig. 1A).53,54 These extracellular potentials are often referred to as local 
field potentials. Populations of neurons often show oscillatory spiking and oscillatory local 
field potentials that are thought to play a primary role in coordinating and modulating 
communication within and among neural circuits.52 Local field potentials produced in the 
cortex can be measured at the scalp as the electroencephalogram (fig. 1B).
The organization of the pyramidal neurons in the cortex favors the production of large local 
field potentials because the dendrites of the pyramidal neurons run parallel with each other 
and perpendicular to the cortical surface (fig. 1C). This geometry creates a biophysical 
transmitting antenna that generates large extracellular currents whose potentials can be 
measured through the skull and scalp as the electroencephalogram.53,55,56 Subcortical 
regions, such as the thalamus (fig. 1D), produce much smaller potentials that are more 
difficult to detect at the scalp since the electric field decreases in strength as the square of 
the distance from its source.56 However, because cortical and subcortical structures are 
richly interconnected, scalp electroencephalogram patterns reflect the states of both cortical 
and subcortical structures.57 Thus, the electroencephalogram provides a window into the 
brain’s oscillatory state.
A growing body of evidence suggests that anesthetics induce oscillations that alter or disrupt 
the oscillations produced by the brain during normal information processing.19,20,57–63 
These anesthesia-induced oscillations are readily visible in the electroencephalogram.
Data Analysis
To show unprocessed electroencephalogram recordings and their spectrograms computed 
with the same methods on comparable displays, we have taken examples from cases of 
patients receiving general anesthesia and sedation at our Institution. These data were 
recorded following a protocol approved by the Massachusetts General Hospital Human 
Research Committee to construct a database of electroencephalogram of recordings of 
patients receiving general anesthesia and sedation. Electroencephalograms were recorded 
using the Sedline monitor (Masimo Corporation, Irvine California). The Sedline electrode 
array records approximately at positions Fp1, Fp2, F7, and F8, with reference approximately 
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1 cm above Fpz and ground at Fpz. We required impedances less than 5kΩ in each channel. 
Our analyses use Fp1 as results were identical for Fp1 and Fp2. We also include analyses of 
human intracranial neurophysiology60 and high-density electroencephalogram20 from 
previous studies.
The spectrograms were computed using the multitaper method64,65 from the unprocessed 
electroencephalogram signals recorded at a sampling frequency of 250 Hz. Individual 
spectra were computed in 3-sec windows with 0.5 sec overlap between adjacent windows. 
Multitaper spectral estimates have near optimal statistical properties64,65 that substantially 
improve the clarity of spectral features. At present, no current electroencephalogram monitor 
displays multitaper spectra or spectrograms. However, we present multitaper spectra in this 
review in order to illustrate the EEG signatures of different anesthetic drugs with the 
greatest clarity.
Time-Domain and Spectral Measures of the Brain’s Sedative and 
Anesthetic States
Many of the changes that occur in the brain with changes in anesthetic states can be readily 
observed in unprocessed electroencephalogram recordings (fig. 2). Different behavioral and 
neurophysiological states induced by anesthetics are associated with different 
electroencephalogram waveforms. For example, fig. 2 shows the electroencephalogram of 
the same patient in different states of propofol-induced sedation and unconsciousness.20,65 
These include the awake state (fig. 2A), paradoxical excitation (fig. 2B), a sedative state 
(fig. 2C), slow and alpha oscillation anesthetic state (fig. 2D), slow oscillation anesthetic 
state (fig. 2E), burst suppression (fig. 2F) and the isoelectric state (fig. 2G). Visualization 
and analysis of the unprocessed electroencephalogram is a form of time-domain 
analysis.64,65 This approach is commonly used in sleep medicine and sleep research to 
define sleep states66 and also in epileptology to characterize seizure states.67
Reading the frequencies and amplitudes from the unprocessed electroencephalogram in real-
time in the operating room is challenging. If the frequencies of the oscillatory components 
were known, then it would be possible to design specific filters to extract these components 
(fig. 3A and B). The more practical and informative solution is to conduct a spectral analysis 
by computing the spectrum (fig. 3C) and the spectrogram (fig. 3D and 4).64,65
For a given segment of electroencephalogram data, the spectrum (fig. 3C) provides a 
decomposition of the segment into its frequency components usually computed by Fourier 
methods.64,65 The advantage of the spectrum is that it shows the frequency decomposition of 
the electroencephalogram segment for all of the frequencies in a given range (fig. 3C) by 
plotting frequency on the x-axis and power on the y-axis. Power is commonly represented in 
decibels, defined as 10 times the log base 10 of the squared amplitude of a given 
electroencephalogram frequency component. Electroencephalogram power can differ by 
orders of magnitude across frequencies. Taking logarithms makes it easier to visualize on 
the same scale frequencies whose power differs by orders of magnitude. The spectrum of a 
given data segment is thus a plot of power (10 log10 (amplitude)2) by frequency.
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The frequency bands in the spectrum are named following a generally accepted convention 
(Table 1). Changes in power in these bands can be used to track the changes in the brain’s 
anesthetic states. In the signal in fig. 3A, the low frequency oscillation has a period of 
approximately 1 cycle/second or 1 Hertz (Hz) (Table 1, slow oscillation), whereas the period 
of the faster oscillation is at approximately 10 Hz (Table 1, alpha oscillation). The spectrum 
(fig. 3C) also shows that this signal has power in the delta range (1 to 4 Hz) and little to no 
power beyond 12 Hz.
In addition to these conventional frequency bands, two other spectral features are commonly 
reported in electroencephalogram analyses in anesthesiology: the median frequency (fig. 3C, 
vertical dashed line) and the spectral edge frequency (fig. 3C, vertical solid line). The 
median frequency is the frequency that divides the power in the spectrum in half68,69 (fig. 
3C), whereas the spectral edge frequency is the frequency below which 95% of the spectral 
power is located.69 In other words, in the frequency range we use in our analyses of 0.1 to 
30 Hz, half of the power in the spectrum lies below the median and 95% of the power lies 
below the spectral edge frequency. In fig. 3C, the median frequency and spectral edge 
frequency are respectively 3.4Hz and 15.9Hz, where the frequency range is 0.1 Hz to 30Hz. 
The median frequency and the spectral edge are displayed on commercial monitors and are 
useful clinically for tracking whether spectrogram power is shifting to lower (lower median 
frequency and spectral edge) or higher (higher median frequency and spectral edge) 
frequencies. As we discuss, the interpretations of these shifts are anesthetic dependent.
The spectrum displays the power content by frequency for only a single segment of 
electroencephalogram data. Use of the spectrum in electroencephalogram analyses during 
anesthesia care requires computing it on successive data segments. Successive computation 
of the spectrum across contiguous, often overlapping, segments of data is termed the 
spectrogram64,65 (fig. 3D). The spectrogram makes it possible to display how the 
oscillations in the electroencephalogram change in time, with changes in the dosing of the 
anesthetics and/or the intensity of arousal-provoking stimuli. The spectrogram is a 3-
dimensional structure (fig. 3D). However, it is plotted in two dimensions by placing time on 
the x-axis, frequency on the y-axis, and power through color coding on the z-axis (fig. 3E). 
As discussed earlier, this 2-dimensional plot of the spectrogram is termed the density 
spectral array.12,13 whereas, the 3-dimensional plot of the spectrogram is termed the 
compressed spectral array (Fig. 3D).10,22 We display the spectrogram as a density spectral 
array, and refer to it as the spectrogram.
Spectral analyses make it easier to visualize frequency content, especially oscillations, and 
to detect subtle changes in frequency structure. Nevertheless, it is important to know both 
the time-domain and spectral representations of a given behavioral or neurophysiological 
state induced by an anesthetic. We present both in our discussions in the following sections 
for commonly used intravenous and inhaled anesthetics.
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Neurophysiology and Clinical Electrophysiology of Selected Intravenous 
Anesthetics
We review the neuropharmacology and clinical electrophysiology of propofol, 
dexmedetomidine and ketamine. For each anesthetic we discuss the putative mechanism 
through which its actions at specific molecular targets in specific neural circuits produce the 
electroencephalogram signatures and associated behavioral changes associated with its 
anesthetic state.
Molecular and Neural Circuit Mechanisms of Propofol
Propofol, the most widely administered anesthetic agent, is used as an induction agent for 
sedation and maintenance of general anesthesia. Low-dose propofol is frequently 
administered either as small boluses or by infusion for surgeries and diagnostic procedures 
that require only sedation.
The molecular mechanism of propofol has been well characterized. Propofol binds post-
synaptically to GABAA receptors where it induces an inward chloride current which 
hyperpolarizes the post-synaptic neurons thus leading to inhibition.70,71 Because the drug is 
lipid soluble and GABAergic inhibitory interneurons are widely distributed throughout the 
cortex, thalamus, brainstem and spinal cord, propofol induces sedation through its actions at 
multiple sites (fig. 4). In the cortex, propofol induces inhibition by enhancing GABA-
mediated inhibition of pyramidal neurons.71 Propofol decreases excitatory inputs from the 
thalamus to the cortex by enhancing GABAergic inhibition at the thalamic reticular nucleus, 
a network which provides important inhibitory control of thalamic output to the cortex. 
Because the thalamus and cortex are highly interconnected, the inhibitory effects of propofol 
lead not to inactivation of these circuits but rather to oscillations in the beta (figs. 3C and 5) 
and alpha (figs. 3D, 6 and 7) ranges. Propofol also enhances inhibition in the brainstem at 
the GABAergic projections from the pre-optic area of the hypothalamus to the cholinergic, 
monoaminergic and orexinergic arousal centers (fig. 4). Decreasing excitatory inputs from 
the thalamus and the brainstem to the cortex enhances hyperpolarization of cortical 
pyramidal neurons, an effect which favors the appearance of slow and delta oscillations on 
the electroencephalogram (figs. 5, 6 and 7).20,60,72
The Electroencephalogram Signatures of Propofol Sedation and Paradoxical Excitation are 
Beta-Gamma Oscillations
The electroencephalogram patterns seen during sedation are organized, regular beta-gamma 
oscillations (figs. 3C and 5) and slow-delta oscillations (fig. 5). The amplitudes of these 
oscillations are larger than those of the gamma oscillations seen in the awake 
electroencephalogram (fig. 2A). When general anesthesia has been maintained by a propofol 
infusion, a similar beta oscillation pattern is visible in patients after extubation as they lie 
quietly prior to transfer to the post-anesthesia care unit. A beta oscillation is also seen during 
paradoxical excitation (fig. 2B), the state of euphoria or dysphoria with movements that can 
occur when patients are sedated. The state is termed paradoxical because a dose of propofol 
intended to sedate results in excitation. Two mechanisms have been proposed to explain 
propofol induced paradoxical excitation. One involves GABAA1-mediated inhibition of 
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inhibitory inputs from the globus pallidus to the thalamus leading to increased excitatory 
inputs from the thalamus to the cortex.46 This mechanism is also the one through which the 
sedative zolpidem is postulated to induce arousal in minimally conscious patients.73 The 
second mechanism, established in simulation studies, postulates that low-dose propofol 
induces transient blockade of slow potassium currents in cortical neurons.74
The Electroencephalogram Signatures of Propofol are Slow-Delta Oscillations on 
Induction
The electroencephalogram patterns observed during propofol general anesthesia depend 
critically on several factors, the most important of which is the rate of drug administration. 
When propofol is administered as a bolus for induction of general anesthesia the 
electroencephalogram changes within 10 to 30 seconds from an awake pattern with high-
frequency, low-amplitude gamma and beta oscillations (fig. 2A) to patterns of high-
amplitude slow and delta oscillations (fig 2E). The slow and delta oscillations appear in the 
spectrogram as increased power between 0.1 to 5 Hz (fig. 6A and 6B, between minutes 0 
and 5) and in the time domain as high amplitude oscillations (fig. 6C, minute 5.5 and fig. 
6D, minute 7.1) The electroencephalogram change is dramatic as the slow-oscillation 
amplitudes can be 5 to 20 times larger than the amplitudes of the gamma and beta 
oscillations seen in the electroencephalogram of an awake patient.43
The appearance of slow and delta oscillations (fig. 2, 6C, 6D) within seconds of 
administering propofol for induction of general anesthesia coincides with loss of 
responsiveness, loss of the oculocephalic reflex, apnea and atonia.46,65 These 
electroencephalogram signatures and the clinical signs are consistent with a rapid action of 
the anesthetic in the brainstem. Following bolus administration, propofol quickly reaches the 
GABAergic inhibitory synapses emanating from the pre-optic area of the hypothalamus onto 
the major arousal centers in the brainstem and hypothalamus (fig. 4). Action of the 
anesthetic at these synapses inhibits the excitatory arousal inputs from the brainstem, 
favoring hyperpolarization of the cortex, the appearance of slow-delta oscillations on the 
electroencephalogram with loss of consciousness.20,60,72 Loss of the oculocephalic reflex is 
consistent with the anesthetic acting at cranial nerve nuclei III, IV and VI in the midbrain 
and pons.46,65 Apnea is most likely due to the drug’s inhibition of the ventral and dorsal 
respiratory centers in the medulla and pons,75 whereas the brainstem component of atonia is 
most likely due to inhibition of the pontine and medullary reticular nuclei.46
Administration of an additional propofol bolus, either prior to or following intubation, can 
result in either enhancement of the slow oscillation or the conversion of the slow oscillation 
into burst suppression (fig. 6B, minutes 7 to 14 and fig. 6D, minute 11.5) Burst suppression 
is a state of unconsciousness and profound brain inactivation in which the 
electroencephalogram shows periods of electrical activity alternating with periods of 
isoelectricity or electrical silence. In the spectrogram, burst suppression appears as vertical 
lines in the spectrogram (fig. 6B, minutes 7 to 14). When propofol is administered as an 
induction bolus, patients, particularly elderly patients, can enter burst suppression directly.76
As the effects of the bolus doses of propofol recede, the electroencephalogram evolves into 
slow-delta oscillation and alpha oscillation patterns (fig. 6A, minute 7 and fig. 6B, minute 
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15). The time of transition from the slow oscillations or burst suppression into a combined 
slow oscillation and alpha oscillation patterns depends on how profound the effect of the 
bolus dose was. Even if no additional propofol is administered after the first bolus, it can 
take several minutes for the transition to occur. The patient in fig. 6A received a second 
bolus dose of 50 mg at minute 5. An infusion of propofol was started at 100 mcg/kg/min. 
Her slow-delta oscillations did not evolve into the slow-delta and alpha oscillations until 
minute 7. In contrast, the patient in fig. 6B stayed in a state of burst suppression from 
minutes 7 to 14 after her two bolus doses of propofol. After the second bolus dose, she 
received no additional propofol or other anesthetics and transitioned into slow-delta and 
alpha oscillations (fig. 6B, minute 15 to 20 and fig. 6D, minutes 17). If following the bolus 
doses, propofol is administered as an infusion to maintain general anesthesia, the patient’s 
electroencephalogram will continue to show the slow-delta and alpha oscillation patterns in 
the surgical plane (fig. 6A, minutes 9 to 26 and fig. 6C, minute 24).
Slow-Delta and Alpha Oscillations are Markers of Propofol-Induced Unconsciousness
Most brain function monitors used in anesthesiology record only a few channels of the 
electroencephalogram from the front of the head. An awake patient with eyes closed and a 
full set of scalp electroencephalogram electrodes will show the well-known eyes-closed 
alpha oscillations in the occipital areas (fig. 7A, Awake Baseline).77 Concomitant with the 
transition to loss of consciousness and the appearance of the slow and alpha oscillations is 
the phenomenon of anteriorization, in which the power in the alpha and beta bands of the 
electroencephalogram shifts from the occipital area to the front of the head (fig. 7A, LOC 
and Unconsciousness).15,19,20
Although loss of consciousness due to propofol has a strong brainstem effect, maintenance 
of unconsciousness involves the brainstem and other brain centers. Studies of propofol-
induced unconsciousness using a high-density (64-lead) electroencephalogram have shown 
that the alpha oscillations are highly coherent across the front of the head during 
unconsciousness (fig. 7A, Unconsciousness).19,20 An explanation for this coherence is that 
propofol could be inducing an alpha oscillation within circuits linking the thalamus and the 
frontal cortex (fig. 7B).57 In contrast, the slow oscillations are not coherent.19,20 Studies of 
patients with intracortical electrodes also show that the slow oscillations induced by bolus 
administration of propofol are not coherent across the cortex (fig. 7C) and serve as a marker 
of phase-limited spiking activity in the cortex (fig. 7C).60 We postulate that the highly 
organized coherent alpha oscillations most likely prevent normal communications between 
the thalamus and cortex, whereas the incoherent slow oscillations represent an impediment 
to normal intracortical communications.20,57,60,78 Together, these two mechanisms likely 
contribute to the patient being unconscious when the slow and alpha oscillations are visible 
in the spectrogram of patients receiving propofol. These highly coherent alpha oscillations, 
incoherent slow oscillations and anteriorization most certainly contribute to the loss of 
frontal-parietal effective connectivity78–80 that is also associated with propofol-induced loss 
of consciousness.
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EEG Signatures of Emergence from Propofol General Anesthesia
When the propofol infusion is discontinued, and the patient is allowed to emerge, the slow 
and alpha oscillations dissipate and are gradually replaced by higher frequency beta and 
gamma oscillations that have lower amplitudes (fig. 6A, minute 25 to 30 and fig. 6B, minute 
23 to 27).20 In the spectrogram this gradual shift to higher frequency beta and gamma 
oscillations appears as a “zipper opening” pattern (fig. 6A, minute 25 to 30 and fig. 6B, 
minute 23 to 27). The decrease in the amplitude is shown by the shift in the spectrum from 
red to yellow. In the unprocessed electroencephalogram, this change is marked by a gradual 
increase in frequency and decrease in amplitude of the oscillations (fig. 6C, minute 24 and 
fig. 6D, minute 17). Simultaneously, there is dissipation of power in the slow and delta 
bands which appears in the time domain as a flattening of the unprocessed 
electroencephalogram. There is also reversal of anteriorization with emergence (fig. 7A, 
ROC and Awake Emergence) with loss of the coherent frontal alpha oscillations and return 
of the coherent occipital alpha oscillations.20 The return of high-frequency power in the 
electroencephalogram is consistent with return of normal cortical activity and indirectly with 
return of normal thalamic and brainstem activity. Brainstem function returns in an 
approximate caudal (medulla and lower pons) to rostral (upper pons and midbrain) 
manner.46,65 Breathing and gagging are controlled in the medulla and lower pons, whereas 
the corneal and oculocephalic reflexes are controlled in the upper pons and the 
midbrain.46,65 Return of brainstem, thalamic and cortical activity are necessary to restore the 
awake state.
Burst Suppression and Medically-Induced Coma
When delivered in a sufficiently high dose, several anesthetics, including propofol, the 
barbiturates, and the inhaled ether drugs, induce burst suppression (figs. 3F, 6B, 6D, minute 
11.5, 8A and 8B).81–84 Burst suppression is induced by hypothermia for surgeries requiring 
total circulatory arrest85 and by administering anesthetics in the intensive care unit for 
cerebral protection to treat intracranial hypertension or to treat status epilepticus.84,86–88 
This latter state is termed a medically-induced coma. If the patient is in burst suppression 
then, as the dose of the anesthetic is increased, the length of the suppression periods between 
the bursts increases. The dose can be increased to the point at which the 
electroencephalogram is isoelectric (fig. 2G). Within the bursts, the electroencephalogram 
can, in some cases, maintain the brain dynamics that were present prior to the start of burst 
suppression.83,89,90 For example, if the patient is in a state of slow and alpha oscillations 
prior to the burst suppression, then the same pattern is present within the bursts (figs. 6B and 
8A). In addition to deep general anesthesia, burst suppression is also observed in other 
conditions of profound brain inactivation including coma,91 and in children with 
significantly compromised brain development.92 The observation that multiple different 
mechanisms induce burst suppression are consistent with a recently proposed neuronal-
metabolic mechanism of burst suppression.83 Transient increases and decreases in 
extracellular calcium, leading to synaptic disfacilitation, could also play a role in 
determining suppression duration.82
The burst suppression ratio or suppression ratio is a time domain measure used to track 
quantitatively the level of burst suppression. The burst suppression ratio is a number 
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between 0 and 1 which measures the fraction of time in a given time interval that the 
electroencephalogram is suppressed.93,94 The burst suppression ratio is displayed on some 
brain function monitors and is one of the measures used in electroencephalogram-based 
indices to assess depth-of-anesthesia.95,96 A refinement of the burst suppression ratio, 
termed the burst suppression probability, has been recently developed (fig. 8C).97 The burst 
suppression probability is a measure of the instantaneous probability of the brain being in a 
state of suppression that can be reliably computed using state-space methods and used to 
track burst suppression in real time and to implement control systems for medical coma.97,98 
A burst suppression probability of 0.5 means a 0.5 probability of being suppressed, whereas 
a burst suppression probability of 0.75 means a 0.75 probability of being suppressed.
Ketamine
Neural Circuit Mechanisms of Ketamine
Ketamine, an anesthetic adjunct and an analgesic, acts primarily by binding to NMDA 
receptors in the brain and spinal cord.45 Ketamine is a channel blocker so that in order to be 
effective, the channel has to be open.99 Because in general, the channels on inhibitory 
interneurons are more active than those on pyramidal neurons, ketamine at low to moderate 
doses has its primary effect on inhibitory interneurons (fig. 9A).100,101 By blocking inputs to 
inhibitory interneurons, ketamine allows downstream excitatory neurons to become 
disinhibited or more active.45 This is why cerebral metabolism increases with low doses of 
ketamine. Hallucinations, dissociative states, euphoria and dysphoria are common with low 
dose ketamine because brain regions, such as the cortex, hippocampus and the amygdala, 
continue to communicate but with less modulation and control by the inhibitory 
interneurons. Information is processed without proper coordination in space and time.45,46 
The hallucinatory effects are likely enhanced by disruption of dopaminergic 
neurotransmission in the prefrontal cortex due in part to increased glutamate activity at non-
NMDA glutamate receptors.102 Analgesia results most likely from the action of ketamine on 
glutamate NMDA receptors at the dorsal root ganglia, the first synapse of the pain pathway 
in the spinal cord where glutamate is the primary neurotransmitter (fig. 9A).99 As the dose 
of ketamine is increased, the NMDA receptors on the excitatory glutamatergic neurons are 
also blocked and consciousness is lost.
The Electroencephalogram Signatures of Ketamine Sedation Are Beta and Gamma 
Oscillations
Given the preference of ketamine for NMDA receptors on inhibitory interneurons, whose 
inhibition results in increased cerebral metabolic rate, cerebral blood flow, and 
hallucinations,103–105 it is no surprise that ketamine is associated with an active 
electroencephalogram pattern. When ketamine is administered alone in low dose, the 
electroencephalogram shows fast oscillations (fig. 9B and 9C) in the high beta, low gamma 
range at between 25 to 32 Hz. The beta-gamma oscillation did not start until 2 minutes after 
the initial ketamine dose. Compared with propofol and dexmedetomidine, discussed below 
in The Electroencephalogram Signatures of Dexmedetomidine are Slow-Delta Oscillations 
and Spindles, the ketamine slow oscillation is less regular (fig. 9C). The sixty-one year-old 
whose spectrogram is shown in fig. 9B required sedation and analgesia for change of a 
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vacuum dressing over a paniculectomy site. At minute 0, she received a 50 mg bolus of 
ketamine in two doses of 30 and 20 mg, 2 minutes apart. The dressing change started at 
minute 10. Five minutes after administering the 20 mg ketamine dose, the patient continued 
to breathe spontaneously, and was unresponsive to verbal commands and the nociceptive 
stimulation from the procedure. Although the beta and gamma oscillations lasted for only 27 
minutes, the sedative effect of being unresponsive to verbal commands persisted for several 
minutes after the beta-gamma oscillations had disappeared.
Dexmedetomidine
Dexmedetomidine is used as a sedative in the intensive care unit and as a sedative and 
anesthetic adjunct in the operating room. Compared with propofol, patients are easily 
arousable when sedated with dexmedetomidine, with minimal to no respiratory depression. 
Unlike propofol and the benzodiazepines, dexmedetomidine cannot also be used as a 
hypnotic agent.
Neural Circuit Mechanisms of Dexmedetomidine
Dexmedetomidine alters arousal primarily through its actions on pre-synaptic α2 adrenergic 
receptors on neurons projecting from the locus ceruleus. Binding of dexmedetomidine to the 
α2 receptors hyperpolarizes locus coeruleus neurons decreasing norepinephrine 
release.106–108 The behavioral effects of dexmedetomidine are consistent with this proposed 
mechanism of action.109 Hyperpolarization of locus ceruleus neurons results in loss of 
inhibitory inputs to the pre-optic area of the hypothalamus (fig. 10A). The pre-optic area 
sends GABAergic and galanergic inhibitory projections to the major arousals centers in the 
midbrain, pons and hypothalamus (fig. 10A).45,46,110 Hence, loss of the inhibitory inputs 
from the locus ceruleus results in sedation due to activation of these inhibitory pathways 
from the pre-optic area to the arousal centers. Activation of inhibitory inputs from the pre-
optic area is postulated to be an essential component of how non-rapid eye movement sleep 
is initiated.111,112 Sedation by dexmedetomidine is further enhanced due to blockage of pre-
synaptic release of norepinephrine, leading to loss of excitatory inputs from the locus 
ceruleus to the basal forebrain, intralaminar nucleus of the thalamus, and cortex113 and to 
thalamocortical connectivity.114
The Electroencephalogram Signatures of Dexmedetomidine are Slow-Delta Oscillations 
and Spindles
The relationship between the actions of dexmedetomidine in the pre-optic area and the 
initiation of non-rapid eye movement sleep is important to appreciate because it helps 
explain the similarities in the electroencephalogram patterns between this anesthetic and 
those observed in non-rapid eye movement sleep. Dexmedetomidine administered as a low-
dose infusion induces a level of sedation in which the patient responds to minimal auditory 
or tactile stimulation. The electroencephalogram shows a combination of slow-delta 
oscillations with spindles, which are 9 to 15 Hz oscillations that occur in bursts lasting 1 to 2 
seconds. (figs. 10B and 11, A and B).43,44 In the frequency domain, the dexmedetomidine 
spindles appear as streaks in the high alpha and low beta bands between 9 to 15 Hz (fig. 
11A). The spindles occur in a similar frequency range as the alpha oscillations seen with 
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propofol, but have much less power than the alpha oscillations (figs. 6A and 6B).43 Because 
the color scales on the spectrograms in figs. 6A, 6B and 11A are the same, the plots provide 
an informative comparison of the amplitudes of the propofol alpha oscillations and the 
dexmedetomine spindles. The dexmedetomidine spindles closely resemble the spindles that 
define stage II non-rapid eye movement sleep.43,44
The slow-delta oscillations are apparent in the spectrogram as power from 0 to 4 Hz (fig. 
11A). The 44 year-old, 59kg female patient, whose spectrogram and time domain traces are 
shown in figs. 11A and 11B, received a loading infusion of dexmedetomidine at 1 mcg/kg 
over 10 minutes, followed by a maintenance dexmedetomidine infusion of 0.65 mcg/kg/hour
—a rate in the intermediate to high end of the sedative range—for the creation of a left 
forearm arteriovenous fistula for dialysis. During the surgery, the patient was sedated, 
meaning that she responded to verbal queries from the anesthesiologist and moved in 
response to nociceptive stimulation from the surgery.
When the rate of the dexmedetomidine infusion is increased, spindles disappear and the 
amplitude of the slow-delta oscillations increase (fig. 11C and 11D). This 
electroencephalogram pattern of slow-delta oscillations closely resembles non-rapid eye 
movement sleep stage III or slow-wave sleep.66 The slow-delta oscillations appear again as 
intense power in the slow oscillation band (fig. 11D). The power in the slow oscillation band 
for the higher dose of dexmedetomidine (fig. 11C) is considerably stronger than the slow 
oscillations for the lower dose of dexmedetomine (fig. 11A). The spectrogram is that of a 48 
year-old, 65kg female patient who received dexmedetomidine as a loading infusion of 
1mcg/kg over 10 minutes and a maintenance infusion of 0.85 mcg/kg/hour for placement of 
a left forearm ateriovenous fistula. The intense slow-delta oscillation persisted for the 
duration of the procedure. During the surgery, the patient was sedated, meaning that she was 
unresponsive to verbal queries from the anesthesiologist and but moved in response to 
changes in the level of nociceptive stimulation from the procedure.
Propofol frontal alpha oscillations (fig. 7A), dexmedetomidine spindles45 (fig. 11A and 
11B) and sleep spindles115 are all thought to be generated by thalamocortical loop 
mechanisms (fig. 7B and 10B). While the propofol frontal alpha oscillations are highly 
coherent and continuous in time19,20,57, the sleep and dexmedetomidine spindles are brief 
and episodic.43 Sleep spindles are a marker for non-rapid eye movement stage II sleep 
which is a state of unconsciousness that is less profound than non-rapid eye movement stage 
III or slow wave sleep.66 Dexmedetomidine spindles are consistent with a light state of 
sedation.43
Propofol-induced slow oscillations likely result from decreased excitatory inputs to the 
cortex due to propofol’s GABAA-mediated inhibition arousal centers in the midbrain, pons 
and hypothalamus (fig. 4). Dexmedetomine-induced slow oscillations likely result from 
decreased excitatory inputs to the cortex due dexmedetomidine’s disinhibition of the 
inhibitory circuits emanating from the pre-optic area of the hypothalamus to the arousal 
centers along with decreased adrenergically-mediated excitatory inputs to the basal 
forebrain, the intralaminar nucleus of the thalamus and to the cortex directly (fig. 10A). 
Propofol-induced slow oscillations gate brief periods of neuronal activity (fig. 7B).60 In 
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contrast, sleep slow-wave oscillations are associated with brief interruptions in neuronal 
activity.116 Similarly, both slow oscillations and spindles under dexmedetomidine are 
smaller than their counterparts under propofol, which may reflect a lower level of disruption 
in neuronal activity under dexemedetomidine compared to propofol.43 Consequently, 
cortical and thalamo-cortical activity are likely to be more profoundly inhibited under 
propofol-induced unconsciousness compared to either slow-wave sleep or 
dexmedetomidine-induced sedation. This difference in cortical and thalamo-cortical activity 
suggests why patients can be aroused from sleep and dexmedetomidine-induced sedation, 
but not from propofol-induced unconsciousness.43,60
Clinical Electrophysiology of the Inhaled Anesthetics
Neurophysiological Mechanisms of Inhaled of Anesthetic Action
The principal inhaled anesthetics are the ether derivatives sevoflurane, isoflurane, and 
desflurane. The inhaled agents are total anesthetics in that they can maintain all of the 
required behavioral and physiological characteristics of general anesthesia without adjunct. 
In practice, the inhaled anesthetics are rarely used alone, but more commonly in conjunction 
with intravenous drugs, nitrous oxide and muscle relaxants to provide balanced general 
anesthesia which maximizes the desired effects while minimizing side effects. The inhaled 
agents are known to create their behavioral and physiological effects through binding at 
multiple targets in the brain and central nervous system including: binding to GABAA 
receptors and enhancing GABAergic inhibition; blockade of 2-pore potassium channels and 
HCN channels; and blocking glutamate release by binding to NMDA receptors.70 Studies of 
minimal alveolar concentration (MAC) have shown that the muscle relaxant effects of the 
inhaled anesthetics are the result of direct action at one or more of these receptors and 
channels in the spinal cord.117 This mechanism is also consistent with the observation that 
spinal cord motor evoked potentials are difficult to record in patients receiving anesthetic 
concentrations of an ether anesthetic.118
Gibbs, Gibbs and Lennox showed that the electroencephalogram of patients receiving ether 
show slow-delta oscillations and alpha oscillations at surgical levels of general anesthesia.1 
When sevoflurane is administered at sub-MAC concentrations to achieve surgical levels of 
general anesthesia the EEG shows slow-delta oscillations and coherent alpha oscillations 
similar to propofol.47 This observation suggests that for sevoflurane, as for propofol, 
enhanced GABAergic inhibition may be its dominant mechanism of action.47 However, 
unlike propofol, sevoflurane also shows a small coherent theta oscillation,47 which may 
reflect one of its non-GABAergic mechanisms.
The Electroencephalogram Signatures of Sevoflurane, Isoflurane and Desflurane are 
Alpha, Slow-Delta and Theta Oscillations
At sub-MAC concentrations, sevoflurane shows strong alpha and slow-delta oscillations 
(fig. 12, A–D) that closely resemble those of propofol (fig. 6). As the concentration of 
sevoflurane is increased to MAC levels and above, a strong theta oscillation appears creating 
a distinctive pattern of evenly distributed power from the slow oscillation range up through 
the alpha range (fig. 12, A and C). This approximately equal power from the slow oscillation 
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range through to the alpha range (fig. 12, A and C) is typical during maintenance with 
sevoflurane at or above MAC. The theta oscillation power appears to fill in between the 
slow-delta and alpha oscillation power. As the concentration of sevoflourane is decreased, 
the theta oscillations dissipate first. This is evident in fig. 12A as the theta oscillations 
dissipate when the concentration of sevoflurane is lowered. On emergence, as in the case of 
propofol (fig. 6A, minute 27 and 6B, minute 25), the alpha oscillations transition to lower 
amplitude beta and gamma oscillations (fig. 12A, minute 180). At the same time, the slow 
and delta oscillations dissipate. The loss of the alpha and slow-delta oscillation power again 
appears in the spectrogram as a zipper opening pattern.
Isoflurane (fig. 12E and 12F) and desflurane (fig. 12G and 12H) have similar patterns to 
sevoflurane (fig. 12 C–D). At sub-MAC concentrations, they also show strong alpha and 
slow-delta oscillations. When the concentration of isoflurane or desflurane is increased to 
MAC levels and above, a theta oscillation fills in between the delta and alpha bands (fig. 
12E, minute 30 and 12G, minute 28). As in the case of sevoflurane, on emergence from 
isoflurane and oxygen or desflurane and oxygen anesthesia, there is loss of the theta 
oscillation power, followed by dissipation of alpha and slow-delta oscillation power, and 
reappearance of the power in the beta and gamma bands (fig. 12E, minutes 78 to 80 and 12 
G, minutes 85 to 90). These observations suggest, that by analogy with sevoflurane, 
enhanced GABAergic inhibition is likely a primary but not the only mechanism through 
which isoflurane and desflurane induce their anesthetic states. This relationship between 
MAC and theta oscillations is useful clinically. The appearance of theta oscillations 
indicates a more profound state of unconsciousness and immobility for an inhaled ether 
anesthetic.
As with propofol, burst suppression can be induced by administering a sufficiently high dose 
of any one of the inhaled ether anesthetic drugs.81,84
High-Amplitude Slow-Delta Oscillations Mark the Transition to High-Flow Nitrous Oxide
Nitrous oxide has been used as a sedative and as an anesthetic since the late 1800s.3,119 
Today, it is most often used as an anesthetic adjunct because, unlike the ether anesthetics, 
nitrous oxide is not sufficiently potent by itself to produce general anesthesia. Attempts to 
administer sufficient doses of only nitrous oxide to produce unconsciousness predictably 
result in nausea and vomiting.41 Unlike the ether anesthetics, administering nitrous oxide 
with oxygen is not commonly thought to produce slow and alpha oscillations. Instead, 
nitrous oxide is associated with prominent beta and gamma40 oscillations and possibly, with 
a relative decrease in power in the slow and delta oscillation bands.41
A common practice at our institution is to use an inhaled ether anesthetic with oxygen for 
maintenance of general anesthesia and to switch to a high concentration of nitrous oxide 
with oxygen with high total flow rates near the end of the case to hasten the patient’s 
emergence. In this situation, a distinctive electroencephalogram pattern appears with the 
transition to nitrous oxide. It is illustrated in fig. 13. In anticipation of emergence, a 34 year-
old patient was maintained on 0.5% isoflurane and 58% oxygen during the last minutes of a 
laprascopic cholecystectomy. At minute 82 the anesthetic was switched to 0.2% isoflurane, 
75% nitrous oxide and 24% oxygen. With the switch, the total flow rate was increased from 
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3 to 7 liters per minute. Two minutes after the switch, the power in the slow, delta and alpha 
bands begins to decline (fig. 13A, minute 84). Four minutes following the switch, a 
profound slow-delta oscillation appears in the electroencephalogram (fig. 13A, minute 86 
and 13B, minute 86). These slow-delta oscillations dominate with near loss of all power 
above 5Hz for approximately 4 minutes (fig. 13, minutes 86 to 90, blue area in the 
spectrogram) before they evolve to the beta-gamma oscillations that are more commonly 
associated with nitrous oxide (fig. 13A, minute 90 and 13B, minute 90). The appearance of 
the beta-gamma oscillations and the loss of the slow-delta oscillations take place from 
minutes 90 to 94. The patient was extubated at minute 110 (not shown).
The appearance of slow-delta oscillations we commonly observe in the switch from one of 
the ether anesthetics, halothane or propofol to a high concentration (> 70%) nitrous oxide 
has been previously reported.120,121 The slow-delta oscillations tend to be transient120,121 
and the beta-gamma oscillations usually reported with nitrous oxide40,41 appear the slow-
delta oscillations dissipate. These slow-delta oscillations are noticeably different from the 
slow-waves seen during propofol induction (fig. 6) and during deep dexmedetomidine 
sedation (fig. 11D) in that they are accompanied by a substantial reduction in spectral power 
at all frequencies above 10 Hz (fig. 13A minutes 86 to 90). Although the mechanism of this 
slow oscillation is unknown, one possible explanation is blockade of NMDA-receptor 
mediated excitatory inputs from the parabrachial nucleus and the median pontine reticular 
formation to the basal forebrain and to the thalamus.122 The beta-gamma oscillations may 
have a mechanism similar to that of ketamine (fig. 9B) whose increased beta-gamma activity 
depends critically on NMDA-mediated inactivation of inhibitory interneurons.45
Discussion
Anesthesiologists administer selected combinations of drugs to create the anesthetic state 
best suited for the patient and the given surgical or diagnostic procedure. A growing body of 
evidence suggests that the behavioral effects of the anesthetics are due to neural oscillations 
induced by their actions at specific molecular targets in specific neural circuits. Anesthesia-
induced oscillations are 5 to 20 times larger than normal brain oscillations, likely disrupt 
normal brain communication (fig. 1) and are readily visible in the unprocessed 
electroencephalogram (fig. 2) and its spectrogram (fig. 3). Therefore, for three widely used 
intravenous anesthetics—propofol, ketamine and dexmedetomidine—we related the 
electroencephalogram signatures to the molecular targets and the neural circuits in the brain 
at which these drugs most likely act (figs. 4–11). For the inhaled ether-derived anesthetics 
sevoflurane, isoflurane and desflurane, we observed that, with the exception of the theta 
oscillations that appear around 1 MAC and beyond, their electroencephalogram patterns 
during maintenance and emergence closely resemble those seen in propofol (fig. 12). 
Nitrous oxide is known to be associated with increased beta and gamma oscillations and 
likely decreased slow-delta oscillations. However, we demonstrated that nitrous oxide also 
produces profound slow-delta oscillations during the transition from an inhaled ether 
anesthetic (fig. 13).
In contrast to brain state monitoring based on the electroencephalogram-derived indices, 
which assume that the same index value defines for any anesthetic the same level of 
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unconsciousness, the unprocessed electroencephalogram and the spectrogram define a 
broader range of brain states. Therefore, under our paradigm, their use should enable a more 
nuanced characterization of brain states guided by mechanistic insights. Our paradigm for 
brain state monitoring differs also from that used by neurologists and clinical 
neurophysiologists. These clinicians commonly use unprocessed electroencephalogram 
patterns to identify seizures in the intensive care unit123,124, to characterize evoked 
potentials123, to detect ischemia during neurophysiological monitoring in the operating 
room125 or to characterize sleep stages.126 Their paradigm relies on identifying patterns in 
the unprocessed electroencephalogram to diagnose seizures or ischemia irrespective of the 
anesthetic. To do so, clinical neurophysiologists frequently ask anesthesiologists to reduce 
or not use certain anesthetics, e.g. not to use ether anesthetics during spinal cord monitoring, 
to facilitate detection of clinically significant changes in unprocessed electroencephalogram 
patterns.127 Hence, the neurologist’s paradigm does not require understanding the 
electroencephalogram signatures of the anesthetics.
Our paradigm synthesizes research from the last 80 years. Gibbs, Gibbs and Lennox showed 
that under general anesthesia electroencephalograms patterns changed with level of 
unconsciousness.1 Several investigators showed that different anesthetics have different 
electroencephalogram patterns and that these patterns were visible in the spectra of the 
electroencephalogram10,12–14,22. In 1959, Martin, Faulconer and Bickford wrote, “The big 
question, of course, remains unanswered; namely, do the electroencephalographic patterns 
defined in the several classifications presented constitute a valid measure of depth of 
anesthesia. We believe that this question unanswerable until a precise definition of ‘depth of 
anesthesia’ is made.”6 Relating the electroencephalogram patterns to the mechanisms was 
not possible at the time because lipid solubility was the primary theory of anesthetic 
mechanisms. The concept that anesthetics bind to specific molecular targets was not 
promulgated until 1984128 and the detailed neural circuit descriptions of how anesthetic 
actions at specific molecular targets could lead to altered states of arousal were not reported 
until more than 25 years later.45,46 In recent years, more has been learned about the 
biophysics of the electroencephalogram53 and about how altered states of arousal induced by 
anesthetics relate to electroencephalogram activity.19,20,43,47,57,60 Hence, it is now possible 
to link electroencephalogram signatures to anesthetic state and the actions of the drugs at 
specific molecular targets and in specific neural circuits (fig. 14).
Today, the unprocessed electroencephalogram and the spectrogram are displayed on several 
brain monitors.31,50,129 Accurate spectral analyses are required to track accurately the 
anesthetic effects. For this reason, we computed our spectrograms using multitaper spectral 
methods. For a given data length, multitaper methods have been shown to be the optimal 
non-parametric spectral techniques in the sense of giving the spectral estimates with the 
highest resolution and the lowest variance.64,65,130 As a result, the multitaper methods make 
it easier to identify the spectral features of anesthetic-specific signatures.
For the information we have covered in Part I to be useful in the management of patients 
receiving general anesthesia and sedation, it is important to describe how the 
electroencephalogram patterns change as different drugs are combined since this is the more 
common scenario in anesthesiology practice. The effects of combinations of anesthetics on 
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the electroencephalogram will be the topic of Part II. An animated version of portions of 
Parts I and II are available at AnesthesiaEEG.com. In Part III we will review the 
neurological examination for anesthesiologists.
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Fig. 1. 
The neurophysiological origins of the electroencephalogram. A. Normal communication in 
the brain through neuronal spiking activity induces oscillatory extracellular electrical 
currents and potentials that are one of the ways information exchange is modulated and 
controlled in the central nervous system. B. The geometry of the neurons in the cortex favors 
the production of large extracellular currents and potentials. C. The electroencephalogram 
recorded on the scalp is a continuous measure of the electrical potentials produced in the 
cortex. D. Because the cortex (orange region) is highly interconnected with subcortical 
regions, such as the thalamus (yellow region), and the major arousal centers in the basal 
forebrain, hypothalamus, midbrain and pons, profound changes in neural activity in these 
areas can result in major changes in the scalp electroencephalogram. Panel A is reproduced 
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with permission from Hughes and Crunelli, Neuroscientist, 2005. Panel B is reproduced 
with permission from Rampil, Anesthesiology, 1998.
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Fig. 2. 
Unprocessed electroencephalogram signatures of propofol-induced sedation and 
unconsciousness. A. Awake eyes open electroencephalogram pattern. B. Paradoxical 
excitation. C. Alpha and beta oscillations commonly observed during propofol-induced 
sedation (Fig. 5). D. Slow-delta and alpha oscillations commonly seen during 
unconsciousness. E. Slow oscillations commonly observed during unconsciousness at 
induction with propofol (fig. 6) and sedation with dexmedetomidine (fig. 11) and with 
nitrous oxide (fig. 13). F. Burst suppression, a state of profound anesthetic-induced brain 
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inactivation commonly occurring in elderly patients,76 anesthetic-induced coma and 
profound hypothermia (fig. 6B and 6D) G. Isoelectric electroencephalogram pattern 
commonly observed in anesthetic-induced coma and profound hypothermia. With the 
exception of the isoelectric state, the amplitudes of the electroencephalogram signatures of 
the anesthetized states are larger than the amplitudes of the electroencephalogram in the 
awake state by a factor of 5 to 20. All electroencephalogram recordings are from the same 
subject.
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Fig. 3. 
Construction of the spectrogram. A. A ten-second electroencephalogram trace recorded 
under propofol-induced unconsciousness. B. The electroencephalogram trace in A filtered 
into its two principal oscillations: the blue curve, an alpha (8 to 12 Hz) oscillation and the 
green curve, a slow-delta (0.1 to 4 Hz) oscillation. C. The spectrum provides a 
decomposition of the electroencephalogram in A in to power by frequency for all of the 
frequencies in a specified range. The range here is 0.1 to 30 Hz. Power at a given frequency 
is defined in decibels as the 10 times the log base 10 of the squared amplitude (10 log10 
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(amplitude)2). The green horizontal line underscores the slow-delta frequency band and the 
blue horizontal line underscores the alpha frequency band used to compute the filtered 
signals in B. The median frequency, 3.4 Hz, (dashed vertical line) is the frequency that 
divides the power in the spectrum in half. The spectral edge frequency, 15.9 Hz (solid 
vertical line) is the frequency such that 95% of the power in the spectrum lies below this 
value. D. The three-dimensional spectrogram (compressed spectral array) displays the 
successive spectra computed on a 32-minute electroencephalogram recording from a patient 
anesthetized with propofol. Each spectrum is computed on a 3-second interval and adjacent 
spectra have 0.5 seconds of overlap. The black curve at minute 24 is the spectrum in C. D. 
The spectrogram in C plotted in two-dimensions (density spectral array). The black vertical 
curve is the spectrum in C. The lower white curve is the time course of the median 
frequency and the upper white curve is the time course of the spectral edge frequency. 
Panels A–E were adapted from Purdon and Brown, Clinical Electroencephalography for the 
Anesthesiologist (2014), with permission from the Partners Healthcare Office of Continuing 
Professional Development.131
Purdon et al. Page 30
Anesthesiology. Author manuscript; available in PMC 2015 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 4. 
Neurophysiological mechanisms of propofol’s actions in the brain. Propofol enhances 
GABAA-mediated inhibition in the cortex, thalamus and brainstem. Shown are three major 
sites of action: post-synaptic connections between inhibitory interneurons and excitatory 
pyramidal neurons in the cortex; the GABAergic neurons in the thalamic reticular nucleus 
(TRN) of the thalamus; and post-synaptic connections between GABAergic projections 
from the pre-optic area (POA) of the hypothalamulus, and the monoaminergic nuclei which 
are the tuberomammillary nucleus (TMN) that releases histamine (His), the locus ceruleus 
(LC), that releases norepinephrine (NE), the dorsal raphé (DR) that releases serotonin 
(5HT); and the cholinergic nuclei which are the basal forebrain (BF), pedunculopontine 
tegmental (PPT) nucleus and the lateral dorsal tegmental (LDT) nucleus that release 
acetylcholine (Ach). This figure is reproduced with permission from Brown, Purdon and 
Van Dort, Annual Review of Neuroscience, 2011.
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Fig. 5. 
Spectrogram and the time-domain signature of propofol-induced sedation. A. Spectrogram 
shows slow-delta oscillations (0.1 to 4 Hz) and alpha-beta (8 to 22 Hz) oscillations in a 
volunteer subject receiving a propofol infusion to achieve and maintain a target effect-site 
concentration of 2 mcg/ml, starting at time zero.20 The subject was responding correctly to 
the verbal, but not to click train auditory stimuli delivered every 4-seconds for the entire 16 
minutes suggesting that she was becoming sedated.20 The lower and upper white curves are 
the median and the spectral edge frequencies respectively. B. Ten-second 
electroencephalogram trace recorded at minute 6 of the spectrogram in A.
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Fig. 6. 
Spectrogram and time-domain electroencephalogram signatures of two patients receiving 
propofol for induction and maintenance of unconsciousness. A. High slow-delta power 
following the 200mg propofol bolus at minute 3 is evident between minutes 3 and 5. The 
electroencephalogram transitions to robust slow-delta and alpha oscillations maintained by a 
propofol infusion at 100mcg/kg/min. The lower and upper white curves are the median and 
the spectral edge frequencies respectively. B. Following bolus doses of propofol the 
patient’s electroencephalogram transitions between 3 different states: slow oscillations 
(minutes 5 to 8) following the 100 mg propofol bolus at minute 3; burst suppression 
(minutes 8 to 15) following two additional 50 mg propofol boluses; and slow-delta and 
alpha oscillations from minutes 15 to 25. Beginning at minute 24 the alpha band power 
decreases and broadens to the beta band. The slow-delta oscillation power decreases after 
minute 24. The dissipation of the slow-delta and alpha oscillation power as the patient 
emerges gives the appearance of a zipper opening. C. Ten-second electroencephalogram 
traces recorded at minute 5.5 (slow-delta oscillations) and minute 24 (slow-delta and alpha 
oscillations) of the spectrogram in A. D. Ten-second electroencephalogram traces showing 
slow oscillations at minute 7.1, burst suppression at minute 11.5 and slow-delta and alpha 
oscillations at minute 17 for the spectrogram in B. Panels A–D were adapted from Purdon 
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and Brown, Clinical Electroencephalography for the Anesthesiologist (2014), with 
permission from the Partners Healthcare Office of Continuing Professional Development.131
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Fig. 7. 
Spatio-temporal characterization of electroencephalogram alpha and slow oscillations 
observed during induction of and recovery from propofol-induced unconsciousness. A. In 
the volunteer subject lying awake with eyes closed, spatially coherent alpha oscillations are 
observed over the occipital area. The alpha oscillations shift to the front of the head with 
loss of consciousness (LOC) where they intensify and become spatially coherent during 
unconsciousness. The alpha oscillations dissipate anteriorly and return to the occipital area 
during return of consciousness (ROC) where they re-intensify and are spatially coherent in 
the eyes-closed awake state. B. During consciousness there is broadband communication 
between the thalamus and the frontal cortex with beta and gamma activity in the 
electroencephalogram. Modeling studies suggest during propofol-induced unconsciousness 
that the spatially coherent alpha oscillations are highly-structured rhythms in thalamocortical 
circuits.57 C. Slow oscillations recorded from grid electrodes implanted in a patient with 
epilepsy, 30 seconds after bolus induction of general anesthesia with propofol. The slow 
oscillations at nearby electrodes (red and green dots) are in phase (red and green traces) 
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whereas the slow oscillation recorded at an electrode 2 centimeters away (blue dot) is out of 
phase (blue trace) with those at the other two locations. Neurons spike only (histograms) in a 
limited time window governed by the phase of the local slow oscillations. These slow 
oscillations are a marker of intracortical fragmentation with propofol as communication 
through spiking activity is restricted to local areas. The spatially coherent alpha oscillations 
and the disruption of neural spiking activity associated with the slow oscillations are likely 
to be two of the mechanisms through which propofol induces unconsciousness. Panel A is 
reproduced from Purdon et al. PNAS, 2013 and Panel B is adapted from Lewis et al. PNAS, 
2012 with permission.
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Fig. 8. 
Characterization of burst suppression. A. The spectrogram in fig. 6B from minute 4 to 
minute 20. Burst suppression in the spectrogram shows as periods of blue (isoelectric 
activity) interspersed with periods of red-yellow (slow-delta and alpha oscillations). The 
horizontal red line shows the principal period of burst suppression. B. Unprocessed 
electroencephalogram recordings corresponding to the spectrogram in A. The horizontal red 
lines at ±5 microvolts are the thresholds which separate burst events (amplitude ≥ 5 
microvolts) from suppression events (amplitude < 5 microvolts) C. The burst-suppression 
probability provides an estimate of the instantaneous probability of the 
electroencephalogram being suppressed.97 Although it is apparent in the spectrogram and in 
the unprocessed electroencephalogram that the period of strong burst suppression extends 
from minute 8 to 16, the burst-suppression probability analysis shows that it does not 
completely subside until minute 17 as in Fig. 6B.
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Fig. 9. 
Neurophysiology and electroencephalogram signatures of ketamine. A. At low doses, 
ketamine blocks preferentially the actions of glutamate NMDA receptors on GABAergic 
inhibitory interneurons in the cortex and subcortical sites such as the hippocampus and the 
limbic system. The antinociceptive effect of ketamine is due in part to its blockade of 
glutamate release from peripheral afferent (PAF) neurons in the dorsal root ganglia (DRG) 
at their synapses on to projection neurons (PN) in the spinal cord. B. Spectrogram showing 
the beta-gamma oscillations in the electroencephalogram of a sixty-one year-old woman 
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who received ketamine sedation for a vacuum dressing change. Blocking the inhibitory 
action of the interneurons in cortical and subcortical circuits helps explain why ketamine 
produces a high-frequency beta oscillation as its electroencephalogram signature. C. Ten-
second electroencephalogram trace recorded at minute 5 from the spectrogram in B. Arrows 
indicates times of ketamine doses. Panel A is reproduced with permission from Brown, 
Lydic and Schiff, New England Journal of Medicine, 2010. Panels B and C were adapted 
from Purdon and Brown, Clinical Electroencephalography for the Anesthesiologist (2014), 
with permission from the Partners Healthcare Office of Continuing Professional 
Development.131
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Fig. 10. 
Neurophysiology of dexmedetomidine. A. Dexmedetomidine acts pre-synaptically to block 
the release of norepinephrine (NE) from neurons projecting from the locus coeruleus (LC) to 
the basal forebrain (BF), the pre-optic area (POA) of the hypothalamus, the intralaminar 
nucleus (ILN) of the thalamus and the cortex. Blocking the release of NE in the POA leads 
to activation of its inhibitory GABAergic (GABA) and galanergic (Gal) projections to dorsal 
raphé (DR) which releases serotonin (5HT), the tuberomamillary nucleus (TMN) which 
releases histamine (His), the LC, the ventral periacqueductal gray (PAG) which releases 
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dopamine, the lateral dorsal tegmental (LDT) nucleus and the pedunculopontine tegmental 
(PPT) nucleus which release acetylcholine (Ach). These actions lead to decreased arousal by 
inhibition of the arousal centers. B. Ten-second electroencephalogram segment showing 
spindles, intermittent 9 to 15 Hz oscillations (underlined in red), characteristic of 
dexmedetomidine sedation. C. The spindles are most likely produced by intermittent 
oscillations between the cortex and thalamus (light green region). Panel A is reproduced 
with permission from Brown, Purdon and Van Dort, Annual Review of Neuroscience, 2011.
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Fig. 11. 
Spectrograms and time-domain electroencephalogram signatures of dexmedetomidine-
induced sedation. A. Spectrogram of a 59 kg patient receiving a 0.65 mcg/kg/hour 
dexmedetomidine infusion to maintain sedation. The spectrogram shows spindles (9 to 15 
Hz oscillations) and slow-delta oscillations. B. Ten-second electroencephalogram trace 
recorded at minute 60 from the spectrogram in A emphasizing spindles (red underlines). C. 
Spectrogram of a 65 kg patient receiving a 0.85 mcg/kg/hour dexmedetomidine infusion to 
maintain sedation. D. Ten-second electroencephalogram trace recorded at minute 40 from 
the spectrogram in C showing the slow-delta oscillations. Panels A–D were adapted from 
Purdon and Brown, Clinical Electroencephalography for the Anesthesiologist (2014), with 
permission from the Partners Healthcare Office of Continuing Professional Development.131
Purdon et al. Page 42
Anesthesiology. Author manuscript; available in PMC 2015 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 12. 
Spectrograms and time-domain electroencephalogram signatures of sevoflurane, isoflurane 
and desflurane at surgical levels of unconsciousness. The inspired concentration of the 
anesthetics is the blue trace in the upper part of each panel. Green arrows below each panel 
are propofol bolus doses. A. At sub-MAC concentrations (minute 40 to minute 60) the 
spectrogram of sevoflurane resembles that of propofol (fig. 6, A and B). As the 
concentration of sevoflurane is increased (minute 100 to minute 120), theta (5 to 7Hz) 
oscillations appear. The theta oscillations dissipate when the sevoflurane concentration (blue 
curve) is decreased. B. Ten-second electroencephalogram trace of sevoflurane recorded at 
minute 39.8 of the spectrogram in A. C. The spectrogram of sevoflurane shows constant the 
alpha, slow, delta and theta oscillations at a constant concentration of 3%. D. Ten-second 
electroencephalogram trace of sevoflurane recorded at minute 30 of the spectrogram in C. E. 
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At sub-MAC concentrations (minute 16 to minute 26) the spectrogram of isoflurane 
resembles that of propofol (fig. 6A, B) and sub-MAC sevoflurane (panel A). Theta 
oscillations strengthen as the isoflurane concentration increases towards MAC. F. Ten-
second electroencephalogram trace of desflurane recorded at minute 40 of the spectrogram 
in E. G. At the sub-MAC concentrations shown here the spectrogram of desflurane 
resembles propofol with very low theta oscillation power. H. Ten-second 
electroencephalogram trace of desflurane recorded at minute 40 of the spectrogram in G. 
Panels A, C, E, and G were adapted from Purdon and Brown, Clinical 
Electroencephalography for the Anesthesiologist (2014), with permission from the Partners 
Healthcare Office of Continuing Professional Development.131
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Fig. 13. 
Slow-delta and beta-gamma oscillations associated with nitrous oxide. A. In anticipation of 
emergence, a patient was maintained on 0.5% isoflurane and 58% oxygen. At minute 82, the 
composition of the anesthetic gases was changed to 0.2% isoflurane (blue curve) in 75% 
nitrous oxide (green curve) and 24% oxygen. The total gas flow was increased from 3 to 7 
liters per minute. The alpha, theta and slow oscillation power decreased between minutes 83 
to 85. At minute 86 the power in the theta to beta bands decreased considerably (blue area) 
as the slow-delta oscillation power increased. At minute 88 the slow-delta oscillation power 
decreased and the beta-gamma oscillations appeared at minute 90. The flow rates and 
anesthetic concentrations were maintained constant between minutes 82 and 91. Isoflurane 
was turned off at minute 91. B. Ten-second electroencephalogram traces of the slow-delta 
oscillation at minute 86.7 and the beta-gamma oscillations at minute 90.8. Panels A and B 
were adapted from Purdon and Brown, Clinical Electroencephalography for the 
Anesthesiologist (2014), with permission from the Partners Healthcare Office of Continuing 
Professional Development.131
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Fig. 14. 
Different anesthetics (propofol, sevoflurane, ketamine and dexmedetomidine), different 
electroencephalogram signatures and different molecular and neural circuit mechanisms. A. 
Anesthetic-specific differences in the electroencephalogram are difficult to discern in 
unprocessed electroencephalogram waveforms. B. In the spectrogram, it is clear that 
different anesthetics produce different electroencephalogram signatures. The dynamics the 
electroencephalogram signatures can be related to the molecular targets and the neural 
circuits at which the anesthetics act to create altered states of arousal. Panels A and B were 
adapted from Purdon and Brown, Clinical Electroencephalography for the Anesthesiologist 
(2014), with permission from the Partners Healthcare Office of Continuing Professional 
Development.131
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Table 1
Spectral Frequency Bands
Name Frequency Range
(Herz, cycles per seconds)
Slow < 1
Delta 1–4
Theta 5–8
Alpha 9–12
Beta 13–25
Gamma 26–80
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